查看購物車
  • Simplified Chinese
  • English
  • Japanese
歐洲基因檢測服務市場報告（2021-2031）範圍、細分、動態和競爭分析
市場調查報告書
商品編碼
1819730

歐洲基因檢測服務市場報告（2021-2031）範圍、細分、動態和競爭分析

Europe Genetic Testing Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 193 Pages | 訂單完成後即時交付

價格

歐洲基因檢測服務市場預計將大幅成長，到 2031 年將達到約 32.8496 億美元，高於 2023 年的 10.4933 億美元。這一成長代表著 2023 年至 2031 年的年複合成長率(CAGR) 為 15.3%。

執行摘要和市場分析

歐洲的基因檢測服務市場主要分為幾個主要區域，包括德國、英國、法國、義大利、西班牙和歐洲其他地區。基因檢測需求激增，目前有各種不同的檢測可用於篩檢各種遺傳疾病。許多罕見遺傳疾病的治療越來越便捷，基因檢測在攜帶者檢測、新生兒篩檢以及預測性和症狀前檢測中的作用也越來越受到認可。歐洲各國已啟動各種項目，以提高公眾對基因檢測優勢的認知，旨在確保高品質標準，為患者提供準確可靠的結果。

市場區隔分析

基因檢測服務市場可根據服務類型、疾病和服務提供者進行分類：

1. 服務類型：市場細分為預測檢測、帶因者檢測、產前檢測、新生兒篩檢、診斷性基因檢測等。 2023年，預測檢測在市場佔有率方面成為領先領域。

2. 疾病：市場也依疾病類型分類，包括癌症、心血管疾病、代謝失調和其他疾病。癌症領域在2023年佔據了最大的市場佔有率，反映出腫瘤學對基因檢測的需求很高。

3. 服務提供者：市場按服務提供者細分為醫院實驗室、診斷實驗室和其他提供者。 2023年，醫院實驗室佔據了最大的市場。

市場展望

個人化醫療領域正在快速發展，並被整合到各種醫療保健系統中。個人化醫療利用基因和環境資料，為個別患者提供個人化醫療服務。這種方法基於這樣一種理念：每位患者都是獨一無二的，可能需要特定的藥物治療。 2003年人類基因組計畫（HGP）的完成，以及基因組定序成本的下降，為個人化醫療鋪平了道路。專注於分子診斷的公司已做好準備，充分利用日益成長的分子層面個人化資料。

在德國，個人化醫療（簡稱個人化醫療，IM）已獲得顯著發展。德國聯邦教育與研究部（BMBF）將個人化醫療列為2010年的優先發展領域，並啟動了「個人化醫療」行動計畫。此外，「十萬人基因組計畫」提升了國家醫療服務體系（NHS）作為領先醫療體系的聲譽，進一步支持了基因檢測服務市場的成長。法國也透過「法國基因組醫學2025」計畫在這一領域取得了進展，該計畫旨在透過大量公共投資，使法國成為基因組醫學領域的領導者。

藥物研發的進步對於提高個人化醫療在疾病診斷中的有效性至關重要。基因組學正迅速成為醫學科學的關鍵領域，徹底改變了疾病診斷和治療的研究方法。基因檢測在藥物基因組學中發揮著至關重要的作用，它加速了藥物的研發進程。

國家洞察

歐洲基因檢測服務市場主要包括英國、德國、法國、義大利、西班牙等國家。 2023年，德國佔據了最大的市場佔有率。醫學遺傳學已成為臨床實踐不可或缺的一部分，為醫療專業人員提供了管理疾病和實施預防措施的寶貴診斷工具。 2022年發表的一項研究強調，德國約有400萬人患有罕見疾病。罕見疾病的日益流行，加上專用檢測試劑盒的開發，正在推動市場成長。例如，2020年，德國報告了約69,697例新的乳癌病例，佔所有癌症病例的11.1%，其中很大一部分病例與BRCA突變有關。

德國政府已採取措施，將BRCA基因檢測納入國家癌症策略，加強高遺傳風險女性的篩檢和風險降低方案。 2022年，非侵入性產前檢測將作為公共報銷服務引入，進一步彰顯了德國促進基因檢測發展的決心。政府舉措、消費者意識的提升以及醫療保健支出的增加等因素預計將推動德國市場的成長。

公司簡介

歐洲基因檢測服務市場的主要參與者包括 Eurofins Scientific SE、Exact Sciences Corp、Laboratory Corp of America Holdings、23andMe Holding Co、Ambry Genetics Corp、Quest Diagnostics Inc、Illumina Inc、F. Hoffmann-La Roche Ltd、NeoGenomics Inc、Cento NV Inc、VERITAS INTERCONTINENTAL 和 GeneDx, LLC。這些公司正在採用各種策略，包括擴張、產品創新和併購，以增強其市場影響力並為消費者提供創新解決方案。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：歐洲基因檢測服務市場格局

  • PEST分析

第5章：歐洲基因檢測服務市場-主要市場動態

  • 市場促進因素
    • 遺傳疾病盛行率上升
    • 提高對個人化醫療的認知和接受度
    • 消費者對直接面對消費者（DTC）基因檢測的偏好日益成長
  • 市場限制
    • 基因檢測的社會和倫理影響
    • 基因服務的可負擔性
  • 市場機會
    • 監管支持
  • 未來趨勢
    • 人工智慧基因檢測
  • 影響分析：

第6章：歐洲基因檢測服務市場分析

  • 2021-2031年歐洲基因檢測服務市場收入
  • 歐洲基因檢測服務市場預測分析

第7章：歐洲基因檢測服務市場分析－依服務類型

  • 預測測試
  • 攜帶者檢測
  • 產前檢查
  • 新生兒篩檢
  • 診斷性基因檢測
  • 其他

第8章：歐洲基因檢測服務市場分析－按疾病

  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 其他疾病

第9章：歐洲基因檢測服務市場分析－依最終用戶

  • 醫院實驗室
  • 診斷實驗室
  • 其他最終用戶

第 10 章：歐洲基因檢測服務市場-國家分析

  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區

第 11 章：基因檢測服務市場-產業格局

  • 概述
  • 基因檢測服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene NV
  • Ancestry Genomics Inc
  • Gene By Gene Ltd
  • SIVOTEC BioInformatics LLC
  • Progenesis
  • Fulgent Genetics, Inc
  • VERITAS INTERCONTINENTAL
  • GeneDx, LLC

第 13 章：附錄

Product Code: TIPRE00009240

The European genetic testing services market is projected to grow significantly, reaching approximately USD 3,284.96 million by 2031, up from USD 1,049.33 million in 2023. This growth represents a compound annual growth rate (CAGR) of 15.3% from 2023 to 2031.

Executive Summary and Market Analysis

The market for genetic testing services in Europe is divided into several key regions, including Germany, the UK, France, Italy, Spain, and the Rest of Europe. The demand for genetic testing has surged, with a wide array of tests now available to screen for various genetic disorders. Treatments for numerous rare genetic conditions are becoming more accessible, and genetic testing is increasingly recognized for its role in carrier testing, newborn screening, and predictive and pre-symptomatic testing. European nations have initiated various programs to enhance public awareness regarding the advantages of genetic testing, aiming to ensure high-quality standards that yield accurate and reliable results for patients.

Market Segmentation Analysis

The genetic testing services market can be categorized based on service type, disease, and service provider:

1. Service Type: The market is segmented into predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, predictive testing emerged as the leading segment in terms of market share.

2. Disease: The market is also divided by disease type, including cancer, cardiovascular diseases, metabolic disorders, and other conditions. The cancer segment held the largest market share in 2023, reflecting the high demand for genetic testing in oncology.

3. Service Provider: The market is segmented by service provider into hospital-based laboratories, diagnostic laboratories, and other providers. Hospital-based laboratories accounted for the largest share of the market in 2023.

Market Outlook

The field of personalized medicine, which leverages genetic and environmental data to tailor healthcare to individual patients, is rapidly evolving and being integrated into various healthcare systems. This approach is grounded in the understanding that each patient is unique and may require specific pharmacological treatments. The completion of the Human Genome Project (HGP) in 2003, along with the decreasing costs of genome sequencing, has paved the way for personalized medicine. Companies specializing in molecular diagnostics are well-positioned to capitalize on the growing repository of personalized data at the molecular level.

In Germany, personalized medicine, referred to as individualized medicine (IM), has gained significant traction. The German Federal Ministry of Education and Research (BMBF) identified personalized medicine as a priority area by 2010, launching the "Individualized Medicine" Action Plan. Additionally, the 100,000 Genomes Project has bolstered the National Health Service's reputation as a leading healthcare system, further supporting the growth of the genetic testing services market. France has also made strides in this area with its "Genomic Medicine France 2025" initiative, which aims to position the country as a leader in genomic medicine through substantial public investment.

The advancement of drug discovery is crucial for enhancing the effectiveness of personalized medicines in diagnosing diseases. Genomics is rapidly becoming a pivotal area in medical science, transforming research methodologies for disease diagnosis and treatment. Genetic testing plays a vital role in pharmacogenomics, which accelerates drug discovery and development processes.

Country Insights

The European genetic testing services market includes key countries such as the UK, Germany, France, Italy, Spain, and others. Germany held the largest market share in 2023. Medical genetics has become integral to clinical practice, providing healthcare professionals with valuable diagnostic tools for managing diseases and implementing preventive measures. A study published in 2022 highlighted that rare diseases affect around four million individuals in Germany. The increasing prevalence of rare diseases, coupled with the development of specialized testing kits, is driving market growth. For instance, in 2020, Germany reported approximately 69,697 new breast cancer cases, accounting for 11.1% of all cancer cases, with a significant portion of these cases linked to BRCA mutations.

The German government has taken steps to include BRCA genetic testing in its national cancer strategy, enhancing screening and risk-reduction options for women at high genetic risk. The introduction of noninvasive prenatal testing as a publicly reimbursed service in 2022 further illustrates the country's commitment to advancing genetic testing. Factors such as government initiatives, rising consumer awareness, and increased healthcare spending are expected to propel market growth in Germany.

Company Profiles

Key players in the European genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Europe Genetic Testing Services Market Landscape

  • 4.1 PEST Analysis

5. Europe Genetic Testing Services Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Genetic Diseases
    • 5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 Social and Ethical Implications of Genetic Testing
    • 5.2.2 Affordability of Genetic Services
  • 5.3 Market Opportunities
    • 5.3.1 Regulatory Support
  • 5.4 Future Trends
    • 5.4.1 Artificial Intelligence-Powered Genetic Testing
  • 5.5 Impact Analysis:

6. Genetic Testing Services Market - Europe Analysis

  • 6.1 Europe Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Genetic Testing Services Market Forecast Analysis

7. Europe Genetic Testing Services Market Analysis - by Service Type

  • 7.1 Predictive Testing
    • 7.1.1 Overview
    • 7.1.2 Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Carrier Testing
    • 7.2.1 Overview
    • 7.2.2 Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Prenatal Testing
    • 7.3.1 Overview
    • 7.3.2 Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 New-born Screening
    • 7.4.1 Overview
    • 7.4.2 New-born Screening: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Diagnostic Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Diagnostic Genetic Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Genetic Testing Services Market Analysis - by Disease

  • 8.1 Cancer
    • 8.1.1 Overview
    • 8.1.2 Cancer: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Cardiovascular Diseases
    • 8.2.1 Overview
    • 8.2.2 Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Metabolic Diseases
    • 8.3.1 Overview
    • 8.3.2 Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Other Diseases
    • 8.4.1 Overview
    • 8.4.2 Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Genetic Testing Services Market Analysis - by End User

  • 9.1 Hospital-Based Laboratories
    • 9.1.1 Overview
    • 9.1.2 Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Overview
    • 9.2.2 Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Other End User
    • 9.3.1 Overview
    • 9.3.2 Other End User: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Genetic Testing Services Market - Country Analysis

  • 10.1 Europe
    • 10.1.1 Europe Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Europe Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United Kingdom: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.2.2 United Kingdom: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.2.3 United Kingdom: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.2.4 United Kingdom: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.3 Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Germany: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.3.2 Germany: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.3.3 Germany: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.3.4 Germany: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.4 France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 France: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.4.2 France: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.4.3 France: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.4.4 France: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.5 Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Spain: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.5.2 Spain: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.5.3 Spain: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.5.4 Spain: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.6 Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Italy: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.6.2 Italy: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.6.3 Italy: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.6.4 Italy: Europe Genetic Testing Services Market Share - by End User
      • 10.1.1.7 Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Europe: Europe Genetic Testing Services Market Share - by Service Type
        • 10.1.1.7.2 Rest of Europe: Europe Genetic Testing Services Market Share - by Disease
        • 10.1.1.7.3 Rest of Europe: Europe Genetic Testing Services Market Share - by Cancer Disease
        • 10.1.1.7.4 Rest of Europe: Europe Genetic Testing Services Market Share - by End User

11. Genetic Testing Services Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Genetic Testing Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Eurofins Scientific SE
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Exact Sciences Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Laboratory Corp of America Holdings
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4andMe Holding Co
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Ambry Genetics Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Quest Diagnostics Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Illumina Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 F. Hoffmann-La Roche Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 NeoGenomics Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Centogene NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ancestry Genomics Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Gene By Gene Ltd
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 SIVOTEC BioInformatics LLC
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Progenesis
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Fulgent Genetics, Inc
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Products and Services
    • 12.15.4 Financial Overview
    • 12.15.5 SWOT Analysis
    • 12.15.6 Key Developments
  • 12.16 VERITAS INTERCONTINENTAL
    • 12.16.1 Business Description
    • 12.16.2 Products and Services
    • 12.16.3 Financial Overview
    • 12.16.4 SWOT Analysis
    • 12.16.5 Key Developments
  • 12.17 GeneDx, LLC
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Genetic Testing Services Market Segmentation
  • Table 2. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 4. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease
  • Table 5. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 8. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 9. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 10. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 11. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 12. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 13. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 14. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 15. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 16. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 17. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 18. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 19. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 20. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 21. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 22. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 23. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 24. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 25. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 26. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 27. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 28. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 29. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 30. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 31. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 32. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 33. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Europe Genetic Testing Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Europe Genetic Testing Services Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Europe Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • Figure 6. Europe Genetic Testing Services Market Share (%) - by Service Type (2023 and 2031)
  • Figure 7. Predictive Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Carrier Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Prenatal Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. New-born Screening: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Diagnostic Genetic Testing: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Others: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Europe Genetic Testing Services Market Share (%) - by Disease (2023 and 2031)
  • Figure 14. Cancer: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Cardiovascular Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Metabolic Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Other Diseases: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Europe Genetic Testing Services Market Share (%) - by End User (2023 and 2031)
  • Figure 19. Hospital-Based Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Diagnostic Laboratories: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Other End User: Europe Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Europe Genetic Testing Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. United Kingdom: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Germany: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. France: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Spain: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Italy: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. Rest of Europe: Europe Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 29. Growth Strategies in Genetic Testing Services Market